ஜநரல் பெருநிறுவன நோக்கம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஜநரல் பெருநிறுவன நோக்கம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஜநரல் பெருநிறுவன நோக்கம் Today - Breaking & Trending Today

Poly Medicure jumps on successfully raising funds via QIP issue


Poly Medicure rose 2.25% to Rs 665 after the company successfully raised Rs 400 crore through qualified institutional placement (QIP) route.Poly Medicure s QIP committee approved allotment of 76,33,587 equity shares to eligible qualified institutional buyers at the issue price of Rs 524 per equity share, aggregating to Rs 400 crore. The QIP issue opened on 15 February 2021 and closed on 18 February 2021.
Allottees who were issued more than 5% of the total equity shares offered in the qualified institutions placement (QIP) are SMALLCAP World Fund (27.25%), Lighthouse India III Equity Investors (15.50%), UTI Mutual Fund (12.61%), Max Life Insurance Company (10%), Abu Dhabi Investment Authority (9.60%) and Ashoka India Opportunities Fund (5.95%).
Poly Medicure proposes to utilize the net proceeds for funding suitable organic and inorganic growth opportunities, ongoing capital expenditure, other long term and short terms requirements, pre-payment and/or repayment of outstandi ....

Abu Dhabi , Abuz Aby , United Arab Emirates , World Fund , Mutual Fund , Abu Dhabi Investment Authority , Ashoka India Opportunities Fund , Max Life Insurance Company , Poly Medicure , Lighthouse India , Capital Market , Qualified Institutional Placement , Stock Market , Sunteck Realty Limited , Lighthouse India Iii Equity Investors , General Corporate Purpose , Uti Mutual Fund , Net Proceeds , Plastic Medical Disposables Surgical Devices , Small Cap , ஒன்றுபட்டது அரபு அமீரகங்கள் , உலகம் நிதி , பரஸ்பர நிதி , அசோகா இந்தியா வாய்ப்புகள் நிதி , அதிகபட்சம் வாழ்க்கை காப்பீடு நிறுவனம் , போலி மருந்து ,

IRB Infrastructure Developers to raise up to Rs 2220 cr via NCD issue


IRB Infrastructure Developers has entered into definitive agreement with India Toll Roads - Foreign Portfolio Investor, for raising of funds by issuance of Non Convertible Debentures up to Rs 2220 crore.
The proceeds will be utilised for repayment of existing loans up to Rs 1600 crore and balance for meeting capex requirements and general corporate purpose.
Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)
Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to ke ....

Irb Infrastructure Developers , India Toll Roads , Portfolio Investor , Non Convertible Debentures , Capital Market , Mo Ney , Corporate Finance , Convertible Bond , Capital Expenditure , General Corporate Purpose , ஐர்ப் உள்கட்டமைப்பு டெவலப்பர்கள் , இந்தியா சுங்கவரி சாலைகள் , போர்ட்‌ஃபோலீயோ முதலீட்டாளர் , மூலதனம் சந்தை , பெருநிறுவன நிதி , மாற்றத்தக்கது பத்திரம் , மூலதனம் செலவு , ஜநரல் பெருநிறுவன நோக்கம் ,